Adipokines in interstitial lung diseases

Respir Physiol Neurobiol. 2023 Sep:315:104109. doi: 10.1016/j.resp.2023.104109. Epub 2023 Jun 30.

Abstract

Interstitial lung diseases (ILD) are a heterogenic group of respiratory diseases with complex pathogenesis. A growing number of evidence suggests role of adipose tissue and it's hormones (adipokines) in pathogenesis of various disorders, including lung tissue diseases. The aim of this study was to assess the concentrations of selected adipokines and their receptors (apelin, adiponectin, chemerin, chemerin receptor - CMKLR1) in patients with IPF (idiopathic pulmonary fibrosis) and sarcoidosis in comparison to healthy controls. We found changes in adipokines concentrations in ILD. Adiponectin concentrations were higher in all respiratory diseases patients in comparison to healthy controls. Apelin concentration in ILD patients was higher then those in healthy subjects. The trend of chemerin and CMKLR1 concentrations were similar, with highest concentrations seen in sarcoidosis. The study shows a difference of adipokines concentrations between patients with ILD and healthy controls. Adipokines are a potential marker and therapeutic target in patients with IPF and sarcoidosis.

Keywords: Adipokines; Adipose tissue; Interstitial lung diseases.

MeSH terms

  • Adipokines
  • Adiponectin
  • Apelin
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Lung Diseases, Interstitial*
  • Respiratory Tract Diseases*
  • Sarcoidosis* / complications

Substances

  • Adipokines
  • Apelin
  • Adiponectin